Sorafenib prolongs survival, but what happens to the symptoms?

J Hepatol. 2012 Jul;57(1):222-3; author reply 223. doi: 10.1016/j.jhep.2012.01.023. Epub 2012 Feb 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Doxorubicin / therapeutic use*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Pyridines / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Benzenesulfonates
  • Pyridines
  • Doxorubicin